Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer.

CONCLUSIONS: Younger men with NMPCa had increased risks of BF and CRPC after high-dose IMRT, and may benefit from more intensive treatments. Our findings should be further tested in prospective studies. PMID: 33127301 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33127301?dopt=Abstract

Source: Urologic Oncology - October 27, 2020 Category: Urology & Nephrology Authors: Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T Tags: Urol Oncol Source Type: research